Creating safer pain relief medications that target specific brain receptors
Developing small molecules to engage an analgesic GPCR in pain unpleasantness neural circuits
This study is working on new medications that can help relieve pain without the risk of addiction or serious side effects, making it safer for people who need pain relief.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10974392 on NIH RePORTER |
What this research studies
This research aims to develop new small molecules that can engage specific receptors in the brain to reduce the unpleasant feelings associated with pain without the risks of addiction or severe side effects. By focusing on non-opioid G protein-coupled receptors (GPCRs), the team hopes to create safer analgesics that can effectively alleviate pain across various conditions. The project involves a multidisciplinary team of experts, including pain biologists and pharmacologists, who will work together to identify and test these new compounds. Patients may benefit from these advancements by experiencing effective pain relief without the dangers associated with traditional opioid medications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from various painful conditions who are seeking effective pain management solutions.
Not a fit: Patients who do not experience pain or have conditions that do not involve pain perception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer pain relief options that minimize the risk of addiction and other harmful side effects.
How similar studies have performed: While the approach of targeting non-opioid GPCRs is innovative, previous research has shown promise in developing safer analgesics, indicating potential for success in this area.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Scherrer, Gregory — Univ of North Carolina Chapel Hill
- Study coordinator: Scherrer, Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.